November 2004

 

Issue

Supplement

COVER STORY

Endovascular Surgery: How We Arrived Here

“…a minimal incision, limited potential for complications, short hospitalization, and rapid recovery are obvious advantages.” —Edward B. Diethrich, MD1

By John Bergan, MD, FACS, FACPh, FRCS Hon. (Eng.)

The EVAR Revolution

An interview with Juan Parodi, MD

The Advent of Stenting

An Interview with Julio Palmaz, MD

Tomorrow’s Gold Standard?

An Interview with Jay Yadav, MD

DEPARTMENTS

The Preclinical Testing of Endovascular Grafts

How the FDA, physicians, and industry are working together to develop new testing and performance standards.

By Dorothy B. Abel and Angela C. Smith

TECHNIQUES

RAA Exclusion With a Viabahn Stent Graft

Covered stent graft technology continues to evolve and allow for treatment of an increasing number of aneurysm types.

By Larry Horesh, MD

An Interview With John R. Laird, Jr, MD

By John R. Laird, Jr, MD

VESSEL UPDATE

CAS Training Programs

Guidant and Cordis recently introduced their carotid stenting training programs, which seek to balance the demand for carotid training with the experience required to perform this procedure.

By Craig McChesney, Publisher

Referral-Based, Reimbursable Screening

A new program offers a unique opportunity to improve patient care by making the primary physician your partner in detecting peripheral arterial disease at its early stages.

By An Interview with Michael R. Jaff, DO, RVT, FACC
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.